Tech Company Financing Transactions
TRiNDS Funding Round
CureDuchenne Ventures participated in a funding round for TRiNDS. The financing was recorded on 12/22/2016.
Transaction Overview
Company Name
Announced On
12/22/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
CureDuchenne Ventures (Jak Knowles)
Proceeds Purpose
CureDuchenne Ventures funding will allow TRiNDS to accelerate its operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Pittsburgh, PA 15222
USA
Pittsburgh, PA 15222
USA
Phone
Website
Email Address
Overview
TRiNDS is a specialized contract research organization (CRO) for neuromuscular diseases. It is a full-service CRO with four main pillars of solutions in clinical operations, data management, biostatistics, and study measurements. It is unique with its focus on muscular dystrophies and study outcome developments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Operating Officer
Lauren Morgenroth
Browse more venture capital transactions:
Prev: 12/22/2016: QSpex Technologies venture capital transaction
Next: 12/22/2016: Revolution Medicines venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs